Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide
Barbara J. Brandhuber, Boulder, CO (US); Lauren T. Brent, San Diego, CA (US); Charles Todd Eary, Longmont, CO (US); Andrew Kenna, San Diego, CA (US); Firas Khan, San Diego, CA (US); Vivian F. H. Renshaw, San Diego, CA (US); and Stacey Renee Spencer, Lyons, CO (US)
Assigned to Loxo Oncology, Inc., Indianapolis, IN (US)
Filed by Loxo Oncology, Inc., Indianapolis, IN (US)
Filed on Feb. 13, 2024, as Appl. No. 18/440,563.
Application 18/440,563 is a division of application No. 17/260,745, previously published as PCT/US2019/043937, filed on Jul. 29, 2019.
Claims priority of provisional application 62/769,308, filed on Nov. 19, 2018.
Claims priority of provisional application 62/729,855, filed on Sep. 11, 2018.
Claims priority of provisional application 62/712,861, filed on Jul. 31, 2018.
Prior Publication US 2024/0238253 A1, Jul. 18, 2024
1. A spray-dried dispersion comprising a compound of Formula I:
or a pharmaceutically acceptable salt thereof and one or more polymers selected from the group consisting of an HPMCAS polymer, an HPMC polymer, a vinylpyrrolidone-vinyl acetate copolymer, and a polyvinylpyrrolidone (PVP) polymer.